Tag: FDA

The Purple Book: Understanding Biosimilars and Interchangeability
Alistair Fothergill 14 March 2026 12 Comments

The FDA's Purple Book is the official resource for understanding which biological drugs are biosimilars and which can be swapped at the pharmacy. Learn how it works, why interchangeability matters, and what it means for patients and providers.

Read More